Print

Epizyme to Participate in Upcoming Conferences in September  
9/4/2012 10:23:09 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, today announced its participation in four upcoming conferences.
//-->